Reference health

Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis

https://doi.org/10.1038/s41467-022-28138-6
CiteStamped reference-health badge
52/52 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 52 checked references that resolve
resolves10.1038/nrgastro.2017.109
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
resolves10.1007/s10620-016-4143-0
Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations
resolves10.1016/j.jhep.2015.02.041
Current efforts and trends in the treatment of NASH
resolves10.1007/s00535-010-0311-8
Prevalence, gender, ethnic variations, and prognosis of NASH
resolves10.1053/j.gastro.2018.04.034
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
resolves10.1111/liv.13709
A simple clinical model predicts incident hepatic steatosis in a community‐based cohort: The Framingham Heart Study
resolves10.1016/j.clinre.2020.06.022
Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea
resolves10.3748/wjg.v18.i3.237
Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women
resolves10.3748/wjg.v13.i47.6419
Prevalence of fatty liver disease and its risk factors in the population of South China
resolves10.1053/gast.2002.33573
Nonalcoholic fatty liver disease
resolves10.1038/s41467-020-15009-1
Structural basis of ligand binding modes at the human formyl peptide receptor 2
resolves10.1016/j.jaut.2017.06.012
Regulation of inflammation by members of the formyl-peptide receptor family
resolves10.1016/j.cmet.2015.05.003
Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease
resolves10.1002/hep.27141
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
resolves10.1371/journal.pone.0100522
Deficiency of Formyl Peptide Receptor 1 and 2 Is Associated with Increased Inflammation and Enhanced Liver Injury after LPS-Stimulation
resolves10.1016/S0016-5085(03)00907-7
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
resolves10.1586/egh.11.6
Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
resolves10.1053/j.gastro.2016.02.066
Pathogenesis of Nonalcoholic Steatohepatitis
resolves10.1007/s10620-016-4049-x
Innate Immunity and Inflammation in NAFLD/NASH
resolves10.1053/j.gastro.2015.05.039
High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery
resolves10.3390/cells8101259
Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
resolves10.1053/j.gastro.2016.09.017
Estrogen Signals Through Peroxisome Proliferator-Activated Receptor−γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease
resolves10.1002/hep.23094
Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis # †
resolves10.1016/S0021-9258(18)69166-5
The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes.
resolves10.1074/jbc.M301982200
A Gender-specific Role For Phosphatidylethanolamine N-Methyltransferase-derived Phosphatidylcholine in the Regulation of Plasma High Density and Very Low Density Lipoproteins in Mice
resolves10.1096/fj.07-8227com
Phosphatidylethanolamine <i>N</i> ‐methyltransferase <i>(PEMT)</i> gene expression is induced by estrogen in human and mouse primary hepatocytes
resolves10.1002/hep.26761
Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis
resolves10.1177/1535370215570189
Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway
resolves10.1111/j.1440-1746.2005.04086.x
Prevalence and risk factors of non‐alcoholic fatty liver disease among Korean adults
resolves10.1002/hep.20543
Chronological development of elevated aminotransferases in a nonalcoholic population
resolves10.1111/iep.12008
An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis
resolves10.1111/iep.12240
Hepatocellular carcinoma in a mouse model fed a choline‐deficient, L‐amino acid‐defined, high‐fat diet
resolves10.3892/ijmm.2016.2483
Lipoxin A4 exerts protective effects against experimental acute liver failure by inhibiting the NF-κB pathway
resolves10.5152/tjg.2019.18276
A bioactive product lipoxin A4 attenuates liver fibrosis in an experimental model by regulating immune response and modulating the expression of regeneration genes
resolves10.1155/2015/294278
Sex Hormones and Their Receptors Regulate Liver Energy Homeostasis
resolves10.1002/rmb2.12006
Molecular mechanism of estrogen–estrogen receptor signaling
resolves10.1111/gtc.12214
Estrogen induces estrogen receptor alpha expression and hepatocyte proliferation in the livers of male mice
resolves10.1111/jgh.13976
Estrogen receptor <b>β</b> selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells
resolves10.2535/ofaj1936.65.1_35
Aging and Longevity of the Jel: ICR Mouse
resolves10.1074/jbc.M114.592352
MicroRNA-181b Regulates ALX/FPR2 Receptor Expression and Proresolution Signaling in Human Macrophages
resolves10.1038/s41598-017-14055-y
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense
resolves10.1016/j.bbrc.2017.09.042
MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1
resolves10.1038/onc.2009.468
TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
resolves10.1016/j.bbalip.2011.09.009
Phosphatidylcholine biosynthesis and lipoprotein metabolism
resolves10.1093/ajcn/85.5.1275
Sex and menopausal status influence human dietary requirements for the nutrient choline
resolves10.1016/j.jhep.2010.06.021
Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C
resolves10.1038/srep05832
Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study
resolves10.1136/gut.2009.204354
Signals from dying hepatocytes trigger growth of liver progenitors
resolves10.4049/jimmunol.0903526
Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation
resolves10.1080/15287397909529766
Hepatocyte suspensions and cultures as tools in experimental carcinogenesis
resolves10.1016/j.biomaterials.2019.119375
Tumor necrosis factor-inducible gene 6 reprograms hepatic stellate cells into stem-like cells, which ameliorates liver damage in mouse
resolves10.1038/ncomms10993
MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression
The 1 reference without a DOI — listed, not checked
no DOI — not checkedTessitore, L., Sesca, E., Greco, M., Pani, P. & Dianzani, M. U. Sexually differentiated response to choline in choline deficiency and ethionine intoxication. Int. J. Exp. Pathol. 76, 125–129 (1995).
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1038/s41467-022-28138-6"><img src="https://citestamp.com/citestamped/10.1038/s41467-022-28138-6/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1038/s41467-022-28138-6/badge.svg)](https://citestamp.com/citestamped/10.1038/s41467-022-28138-6)